Catalyst Pharmaceuticals
CPRX
#3529
Rank
โ‚น357.23 B
Marketcap
โ‚น2,918
Share price
0.00%
Change (1 day)
62.16%
Change (1 year)

EPS for Catalyst Pharmaceuticals (CPRX)

EPS in 2026 (TTM): โ‚น162.27

According to Catalyst Pharmaceuticals's latest financial reports the company's current EPS (TTM) is โ‚น167.73. In 2025 the company made an earnings per share (EPS) of โ‚น163.10 an increase over its 2024 EPS that were of โ‚น128.81.

EPS history for Catalyst Pharmaceuticals from 2015 to 2026

Annual EPS

Year EPS Change
2026 (TTM)โ‚น162.27-0.51%
2025โ‚น163.1026.62%
2024โ‚น128.81
2022โ‚น74.14110.53%
2021โ‚น35.21-47.22%
2020โ‚น66.72132.26%
2019โ‚น28.73-191.18%
2018-โ‚น31.5154.55%
2017-โ‚น20.39-4.35%
2016-โ‚น21.31-8%
2015-โ‚น23.17

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
โ‚น619.02 269.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
โ‚น65.80-60.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
โ‚น250.57 49.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
-โ‚น243.72-245.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Acorda Therapeutics
ACOR
-โ‚น4,662-2,879.56%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
-โ‚น8.34-104.97%๐Ÿ‡บ๐Ÿ‡ธ USA